000			02016 a2200577 4500
005			20250513201838.0
264		0	_c20000127
008			200001s 0 0 eng d
022			_a0368-2811
024	7		_a10.1093/jjco/29.10.485 _2doi
040			_aNLM _beng _cNLM
100	1		_aTakenaka, T
245	0	0	_aAlternating combination chemotherapy COP (cyclophosphamide, vincristine, prednisone) and MP (melphalan, prednisone) in multiple myeloma: a multicenter phase II study (JCOG8906). Lymphoma Study Group of the Japan Clinical Oncology Group. _h[electronic resource]
260			_bJapanese journal of clinical oncology _cOct 1999
300			_a485-9 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Evaluation
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMelphalan _xadministration & dosage
650	0	4	_aMiddle Aged
650	0	4	_aMultiple Myeloma _xdrug therapy
650	0	4	_aPrednisone _xadministration & dosage
650	0	4	_aSurvival Rate
650	0	4	_aVincristine _xadministration & dosage
700	1		_aShirakawa, S
700	1		_aMikuni, C
700	1		_aSai, T
700	1		_aShimamoto, Y
700	1		_aAraki, K
700	1		_aHirano, M
700	1		_aMiura, A
700	1		_aOhno, Y
700	1		_aIchimaru, M
700	1		_aHanada, S
700	1		_aInaba, S
700	1		_aKonishi, H
700	1		_aToki, H
700	1		_aTajima, K
700	1		_aNiimi, M
700	1		_aFukuda, H
700	1		_aShimoyama, M
773	0		_tJapanese journal of clinical oncology _gvol. 29 _gno. 10 _gp. 485-9
856	4	0	_uhttps://doi.org/10.1093/jjco/29.10.485 _zAvailable from publisher's website
999			_c10601042 _d10601042